Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.
Conti AG. et al, (2026), Nat Immunol
High throughput mutational characterization of the GPCR ligand C5a using yeast display and deep sequencing.
Xu Y. et al, (2026), Structure, 34, 184 - 197.e4
Promises under pressure: the modest predictive power of polygenic risk scores.
Horton R. et al, (2026), Eur J Hum Genet
Photon FLASH spares radiation-induced changes in cardiac function, remodelling and arrythmia in a preclinical model.
Ghita-Pettigrew M. et al, (2026), Radiother Oncol, 216
Correction: Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England.
Buckell J. et al, (2026), Br J Cancer, 134, 175 - 176
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.
Phillips R. et al, (2026), Br J Cancer, 134, 289 - 294
Lactation, tissue-resident immunity, and protection against breast cancer.
Little M. et al, (2026), Trends Immunol, 47, 3 - 5
Quantifying the flash effect and its dependence on average dose rate in vivo for 6 MeV electron and 6 MV photon beams.
Paillas S. et al, (2026), Clin Transl Radiat Oncol, 56
Specialised or Generic? Tokenization Choices for Radiology Language Models
Warr H. et al, (2026), Lecture Notes in Computer Science, 16146 LNCS, 62 - 70
High-Affinity Peptide-Drug Conjugate Ligands for the TRIM24 PHD and Bromodomain.
Platt MA. et al, (2025), Chemistry, 31
Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.
Xu A. et al, (2025), Circulation, 152, 1705 - 1727
Mathematical Modeling Quantifies "Just-Right" APC Inactivation for Colorectal Cancer Initiation.
Brunet Guasch M. et al, (2025), Cancer Res, 85, 5113 - 5127
Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy.
Matsubara Y. et al, (2025), Br J Cancer
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.
Walewska R. et al, (2025), Br J Haematol, 207, 2296 - 2313
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.
Cortés J. et al, (2025), Clin Cancer Res, 31, 4953 - 4963
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis.
Kazmi F. et al, (2025), Clin Oncol (R Coll Radiol), 48
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Sato T. et al, (2025), Clin Cancer Res, 31, 5027 - 5036